A phase II trial of huperzine A in mild to moderate Alzheimer disease

M. S. Rafii, S. Walsh, J. T. Little, K. Behan, B. Reynolds, C. Ward, S. Jin, R. Thomas, P. S. Aisen

Research output: Contribution to journalArticlepeer-review

149 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of huperzine A in mild to moderate Alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences